QSAR STUDY OF HCV NS5B POLYMERASE INHIBITORS USING THE GENETIC ALGORITHM-MULTIPLE LINEAR REGRESSION (GA-MLR)

被引:0
作者
Rafiei, Hamid [1 ]
Khanzadeh, Marziyeh [2 ]
Mozaffari, Shahla [2 ]
Bostanifar, Mohammad Hassan [1 ]
Avval, Zhila Mohajeri [2 ]
Aalizadeh, Reza [3 ]
Pourbasheer, Eslam [2 ]
机构
[1] Islamic Azad Univ, Dashtestan Branch, Dept Chem, Dashtestan, Iran
[2] PNU, Dept Chem, POB 19395-3697, Tehran, Iran
[3] Univ Athens, Dept Chem, Analyt Chem Lab, Athens 15771, Greece
来源
EXCLI JOURNAL | 2016年 / 15卷
关键词
QSAR; Genetic algorithms; Multiple linear regression; HCV; HEPATITIS-C; RNA-POLYMERASE; IDENTIFICATION; ANTAGONISTS; PREVENTION; PREDICTION; STRATEGY; THERAPY; INDEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Quantitative structure-activity relationship (QSAR) study has been employed for predicting the inhibitory activities of the Hepatitis C virus (HCV) NS5B polymerase inhibitors. A data set consisted of 72 compounds was selected, and then different types of molecular descriptors were calculated. The whole data set was split into a training set (80 % of the dataset) and a test set (20 % of the dataset) using principle component analysis. The stepwise (SW) and the genetic algorithm (GA) techniques were used as variable selection tools. Multiple linear regression method was then used to linearly correlate the selected descriptors with inhibitory activities. Several validation technique including leave-one-out and leave-group-out cross-validation, Y-randomization method were used to evaluate the internal capability of the derived models. The external prediction ability of the derived models was further analyzed using modified r(2), concordance correlation coefficient values and Golbraikh and Tropsha acceptable model criteria's. Based on the derived results (GA-MLR), some new insights toward molecular structural requirements for obtaining better inhibitory activity were obtained.
引用
收藏
页码:38 / 53
页数:16
相关论文
共 50 条
  • [41] QSAR study of IKKβ inhibitors by the genetic algorithm: multiple linear regressions
    Pourbasheer, Eslam
    Aalizadeh, Reza
    Ganjali, Mohammad Reza
    Norouzi, Parviz
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (01) : 57 - 66
  • [42] Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
    Harikishore, Amaravadhi
    Li, Enlin
    Lee, Jia Jun
    Cho, Nam-Joon
    Yoon, Ho Sup
    MOLECULAR DIVERSITY, 2015, 19 (03) : 529 - 539
  • [43] Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
    Amaravadhi Harikishore
    Enlin Li
    Jia Jun Lee
    Nam-Joon Cho
    Ho Sup Yoon
    Molecular Diversity, 2015, 19 : 529 - 539
  • [44] 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase
    Hendricks, Robert T.
    Spencer, Stacey R.
    Blake, James F.
    Fell, Jay B.
    Fischer, John P.
    Stengel, Peter J.
    Leveque, Vincent J. P.
    LePogam, Sophie
    Rajyaguru, Sonal
    Najera, Isabel
    Josey, John A.
    Swallow, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 410 - 414
  • [45] Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors
    Canales, Eda
    Carlson, Joseph S.
    Appleby, Todd
    Fenaux, Martijn
    Lee, Johnny
    Tian, Yang
    Tirunagari, Neeraj
    Wong, Melanie
    Watkins, William J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4288 - 4292
  • [46] 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymerase
    Li, Wenlian
    Si, Hongzong
    Li, Yang
    Ge, Cuizhu
    Song, Fucheng
    Ma, Xiuting
    Duan, Yunbo
    Zhai, Honglin
    JOURNAL OF MOLECULAR STRUCTURE, 2016, 1117 : 227 - 239
  • [47] Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase
    Venkatraman, Srikanth
    Velazquez, Francisco
    Gavalas, Stephen
    Wu, Wanli
    Chen, Kevin X.
    Nair, Anilkumar G.
    Bennett, Frank
    Huang, Yuhua
    Pinto, Patrick
    Jiang, Yueheng
    Selyutin, Oleg
    Vibulbhan, Bancha
    Zeng, Qingbei
    Lesburg, Charles
    Duca, Jose
    Huang, Hsueh-Cheng
    Agrawal, Sony
    Jiang, Chuan-kui
    Ferrari, Eric
    Li, Cheng
    Kozlowski, Joseph
    Rosenblum, Stuart
    Shih, Neng-Yang
    Njoroge, F. George
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) : 2007 - 2017
  • [48] II. Novel HCV NS5B polymerase inhibitors: Discovery of indole C2 acyl sulfonamides
    Anilkumar, Gopinadhan N.
    Selyutin, Oleg
    Rosenblum, Stuart B.
    Zeng, Qingbei
    Jiang, Yueheng
    Chan, Tin-Yau
    Pu, Haiyan
    Wang, Li
    Bennett, Frank
    Chen, Kevin X.
    Lesburg, Charles A.
    Duca, Jose
    Gavalas, Stephen
    Huang, Yuhua
    Pinto, Patrick
    Sannigrahi, Mousumi
    Velazquez, Francisco
    Venkatraman, Srikanth
    Vibulbhan, Bancha
    Agrawal, Sony
    Ferrari, Eric
    Jiang, Chuan-kui
    Huang, H. -C.
    Shih, Neng-Yang
    Njoroge, F. George
    Kozlowski, Joseph A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 713 - 717
  • [49] QSAR study of IKKβ inhibitors by the genetic algorithm: multiple linear regressions
    Eslam Pourbasheer
    Reza Aalizadeh
    Mohammad Reza Ganjali
    Parviz Norouzi
    Medicinal Chemistry Research, 2014, 23 : 57 - 66
  • [50] Prediction of drug-binding sites in HCV NS5B polymerase: MD simulation study
    Tiwari, Gargi
    Pandey, Vishnudatt
    Ojha, Rajendra Prasad
    EMERGING MATERIALS RESEARCH, 2017, 6 (02) : 239 - 248